5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid)
C26H23F6N5O4S — CID 53239860
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid)
5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid) (PubChem CID 53239860) has the molecular formula C26H23F6N5O4S and a molecular weight of 615.56 g/mol. Its IUPAC name is 5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid).
Molecular Properties
| Compound Name | 5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid) |
|---|---|
| PubChem CID | 53239860 |
| Molecular Formula | C26H23F6N5O4S |
| Molecular Weight | 615.56 g/mol |
| Exact Mass | 615.14 |
| IUPAC Name | 5-(4-methylphenyl)-4-(4-pyridin-4-ylpiperazin-1-yl)thieno[2,3-d]pyrimidine;bis(2,2,2-trifluoroacetic acid) |
| SMILES | Cc1ccc(-c2csc3ncnc(N4CCN(c5ccncc5)CC4)c23)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C22H21N5S.2C2HF3O2/c1-16-2-4-17(5-3-16)19-14-28-22-20(19)21(24-15-25-22)27-12-10-26(11-13-27)18-6-8-23-9-7-18;2*3-2(4,5)1(6)7/h2-9,14-15H,10-13H2,1H3;2*(H,6,7) |
| InChIKey | RAAUWHLWXMJJTG-UHFFFAOYSA-N |
| XLogP | 5.65 |
| TPSA | 119.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 615.56 |
| LogP ≤ 5 | 5.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53239860 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.